Abstract: Studies indicate that leptin is involved in not only energy expenditure and food intake, but also in protection against apoptosis, in inflammation and in stimulation of proliferation in many cell types. However, leptin treatment increases the oxidative stress in many cell culture studies. This contradiction evoked a question of whether leptin acts as an oxidant or antioxidant on glial cells. We investigated the effect of leptin on glial cell survival and hydrogen peroxide (H2O2)-induced toxicity in vitro. The survival rate of the cells was determined by using 3-(4,5-D-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, thyazolyl blue (MTT) method. The cells obtained from the whole brain of 1-3 day-old rat were treated with 1, 10, 100 and 1000 ng/mL leptin for 24 or 72 h . Either the pretreatment of leptin alone for 5 h or leptin combined simultaneously with H2O2 or well known antioxidant glutathione (GSH) were applied to the cells. Malondialdehyde (MDA) levels were measured in cell lysates to which leptin was added for 24 h. The 100 and 1000 ng/mL leptin treatment for 72 h increased the glial viability by 19% and 36%, respectively. The dose of H2O2 that killed 75% of the cells was determined as 100 µM. GSH at different doses was applied as a positive control to the cells and the dose of 500 µM completely eliminated toxic effect of 100 µM H2O2. Either the pretreatment of leptin alone for 5 h or leptin combined simultaneously with H2O2 could not eliminate H2O2-caused toxicity. Furthermore, respective leptin doses did not change the glia MDA level. We suggest that leptin can increase glia survival dose dependently, but can not eliminate H2O2-induced oxidation in primary mixed glial cell culture.
Introduction
Leptin hormone, discovered in 1994, is produced mainly by adipose tissue, during pregnancy by placental tissue and, at lower levels by gastric epithelium and muscles. The brain has also been suggested to produce leptin (Wiesner et al. 1999 ) and leptin receptors are widely expressed throughout the brain of mouse (Huang et al. 1996) , rat (Shioda et al. 1998) , and human (Couce et al. 1997) . It regulates the body weight and energy expenditure (Fantuzzi & Faggioni 2000) . It has been shown that leptin has also proliferative effects in many cell types. For example, it induces proliferation of pancreatic β-cell line through activation of mitogen-activated protein kinase (Tanabe et al. 1997) . Another study demonstrated that leptin is a proliferative and migratory factor for rat aortic smooth muscle cells (Oda et al. 2001) . Leptin promotes survival of human circulating blood monocytes prone to apoptosis (Souad & Sanchez-Margalet 2002) . Brown et al. (2005) suggested that endogenous leptin may be a critical factor promoting cell survival in the brain. It has been shown that leptin has also antiapoptotic effects in human neuronal cells (Russo et al. 2004) . Conversely, Jin et al. (1999) indicated that leptin inhibits cell growth in the human HP75 and in the rat pituitary GH 3 cell lines. It is not known whether leptin exerts trophic/survival activities on glial cells. Therefore, the first aim of our study was to seek the possible trophic/survival effect of leptin on primary mixed glial cells.
It is generally accepted that massive neuronal death due to oxidative stress is a regular feature of brain in neurodegenerative diseases. However, much less attention has been given to the death of glial cells (Kitamura et al. 1999) . Previous studies indicated that, in neuron-glia co-culture systems, glial cells protect neuronal cells against hydrogen peroxide (H 2 O 2 ) toxicity by maintaining the neuronal glutathione (GSH) level or by directly scavenging free radicals (Iwata-Ichikawa et al. 1999) . There are data indicating that leptin has antioxidant capacity. A recent finding of the restoration of the defective antioxidant enzyme activity after leptin treatment in ob/ob mice suggests a putative role of leptin in modulation of antioxidant enzyme activity (Watson et al. 1999 ). It has recently been shown that leptin exhibits neuroprotective effects against ischemic neuronal injury (Zhang et al. 2007) . In contrary with these findings, it has been postulated that the increase in systemic leptin levels enhances the oxidative stress, and lowers the antioxidant defence (Balasubramaniyan et al. 2003) . Kutlu et al. (2005) indicated that exogenous leptin increases lipid peroxidation and inhibits antioxidant system in the mouse brain. The results of another study suggested that leptin induces nitric oxide synthase type II (iNOS) in C6 glioma cells (Mattace Raso et al. 2006) . Furthermore, leptin induces oxidative stress in human umblical vein endothelial cells (Bouloumie et al. 1999) . There have been very few studies examining the effects of leptin on oxidative stress on glial cells. This contradiction evoked a question of whether leptin acts as an oxidant or antioxidant on glial cells. The second aim of this study was therefore to compare the effect of exogenous GSH, as a control, with leptin on H 2 O 2 -induced oxidation of rat primary mixed glial cells in culture. Furthermore, the levels of malondialdehyde (MDA) which is a breakdown product of lipid peroxidation, were measured in leptin-treated glial cells.
Material and methods
All the reagents were purchased from Sigma Chemical Co. (St Louis, MO, USA). The glial cells were prepared from whole brains of neonatal Spraque-Dawley rats as described previously with modifications (Richter-Landsberg & Vollgraf 1998). Briefly, the glial cells obtained from the whole brain of 4 rats aged 1-3 days were combined and then cultured in a humidified atmosphere of 5% CO2, at 37
• C in 25 cm 2 flasks. The culture medium consists of Dulbecco's Modified Eagle's Medium (DMEM), 10% fetal bovine serum (FBS) and 1% penicilin-streptomycine solution (antibiotics). The cells were determined as glia by using glial fibrillary acidic protein antibody by immunohistochemical staining kit. When confluence was achieved, the glial cells were dissociated with trypsin-EDTA (0.25%) and centrifuged at 56 g, 4
• C for 5 min. The supernatant was discarded and the samples were counted with a Coulter counter. The glial cells were seeded in 96 well plates (2 × 10 4 cells/well) and incubated for 24 h in 8 wells for the control and 8 wells for each tested drug dose. When applicable, the 3-(4,5-Dmethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, thyazolyl blue (MTT) test was applied for viability and cytotoxicity assays (Mossmann 1983) . The optical density read from the drug-treated wells was converted to a percentage of living cells against the control using the following formula:
Absorbance of treated cells in each well × 100 / the mean absorbance of control cells Data were expressed as the mean percent fraction of control ± standard error of mean (SEM). Statistical significance was ascertained by one way analysis of variance, followed by Tukey's multiple comparison test. The results are means of at least three independent assays and the p value less than 0.05 was considered to be significant.
Cell viability assays
Control group: DMEM supplemented with 1% FBS and 1% antibiotics. Leptin group: treated with 1, 10, 100 or 1000 ng/mL leptin for 24 or 72 h. The growth medium of proliferation assays consisted of DMEM, 1% FBS and 1% antibiotics. Rat leptin was dissolved in phosphate buffered saline which consists of 8% bovine serum albumin (30 mg/mL) and diluted in DMEM.
Cytotoxicity assays
The cells in the following groups were grown for 3 h in a serum-free medium which was then removed and the fresh medium added for 24 h. Control group: DMEM only. H2O2 group: treated with 10, 50, 100, 200 or 300 µM H2O2. GSH group: treated with 100, 200, 500 or 1000 µM GSH. H2O2 + GSH group: treated with 100 µM H2O2 plus 100-1000 µM GSH simultaneously. Leptin pretreatment + H2O2 group: preincubated with respective leptin doses for 5 h, then washed out and 100 µM H2O2 added. H2O2 + leptin group: treated with 100 µM H2O2 plus respective doses of leptin.
MDA measurement
The glial cells were seeded in 30 mm dishes (0.6 × 10 6 cells/dish). When confluence was achieved, the cells were treated with 1, 10, 100 or 1000 ng/mL leptin for 24 h after which the cells were lysed by distilled water, sonicated and stored at −80
• C until measurement. MDA level was measured according to the procedure published previously (Ohkawa et al. 1979) .
Results

Cell viability assays
Although 1 and 10 ng/mL leptin doses applied for 72 h did not change the number of live cells, 100 and 1000 ng/mL leptin increased the percentage of living glial cells by 19% (p < 0.05) and 36%, respectively (p < 0.001; Fig. 1 ). The treatment of glial cells with respective leptin doses for 24 h did not show any negative or positive effect on the cell number ( 
Cytotoxicity assays
All the doses of H 2 O 2 we used decreased the cell number approximately by 11, 22, 75, 79 and 80%, respectively (Fig. 2) . Since 100 µM H 2 O 2 induced approximately 75% cell death, we used this dose for further experiments. Since it is a well known protective agent, GSH was chosen as a positive control. GSH was protective starting from 100 µM, but 500 and 1000 µM doses completely eliminated toxic effect of H 2 O 2 (Fig. 3) . While 100 µM GSH group was significantly different from both the control and H 2 O 2 group (p < 0.05), the higher GSH groups were different from only H 2 O 2 group (p < 0.001). When GSH was applied alone, there was not any effect on glia survival (data not shown).
Neither leptin pretreatment for 5 h nor leptin combined simultaneously with 100 µM H 2 O 2 for 3 h could not eliminate the H 2 O 2 -caused toxicity (Fig. 4) . All the leptin groups were statistically different from the control (p < 0.001), but not from 100 µM H 2 O 2 group.
MDA measurement
Levels of MDA which is a breakdown product of lipid peroxidation were not statistically significant in the 1, 10, 100 or 1000 ng/mL doses of leptin groups when compared to the control (Fig. 5) .
Discussion
In the present study, we showed that high dose of leptin increased viable mixed glial cell number in both timeand dose-dependent manners. Although the treatment of glial cells from the whole brain with 1-1000 ng/mL leptin doses for 24 h did not affect cell proliferation, 100 and 1000 ng/mL leptin in 72 h increased the glial cell number by 19% and 36 %, respectively. This is not very surprising, since leptin receptors are expressed in many brain areas, including hypothalamus, cerebellum, cortex, hypocampus, thalamus, coroid plexus and brain capillary endothelium (Wiesner et al. 1999) . Furthermore, leptin receptors are widely expressed throughout the brain of rat (Shioda et al. 1998) . Hosoi et al. (2000) showed that mouse primary cultured glial cells from whole brain express leptin receptor isoforms, ObRa and Ob-Rb. It is known that leptin affects by acting on leptin receptor isoforms. Russo et al. (2004) cultured SH-SY5Y neuroblastoma cells which were employed as an in vitro model of human neuronal cells, in serumfree DMEM for 24-48 h in the presence or absence of leptin (0-1 µM). They determined the cell number by the colorimetric Naphtalene Blue Black assay and suggested that leptin increases neuronal cell number in a dose-dependent manner. It is well known that leptin is involved in stimulation of proliferation in other cell types (Tanabe et al. 1997; Oda et al. 2001; Souad & Sanchez-Margalet 2002) . For example, 1 and 5 nM leptin increased viable cell numbers of isolated rat pancreatic islets (Tanabe et al. 2001) . Burguera et al. (2006) described that leptin may increase bone mass by stimulating osteoblast proliferation through activation of the PI(3)-K and mitogen-activated protein kinase signaling pathways. Therefore, there are many studies on differ-ent cell types that support our results. Finally, in agreement with our 24 h leptin treatment, Mattace-Rasso et al. (2006) suggested that no change in cell proliferation was observed when C6 cells were treated only for 22 h with 1, 3 or 10 µg/mL leptin. Recent investigations indicate that neurons are particularly sensitive to H 2 O 2 . The neurotoxic effect of H 2 O 2 on neurons co-cultured with astrocytes was strongly attenuated compared with that observed on a pure population of neurons seeded at the same density. Moreover, the protective effect of astrocytes depended on the astrocytes/neurons ratio, a significant neuroprotection being detectable for the ratio 1 astrocyte to 20 neurons (Desagher et al. 1996) . Therefore, improving astrocyte survival should lead to neuroprotection. The other aim of the present study was to evaluate the effect of leptin on H 2 O 2 -induced cell toxicity. When applied simultaneously with H 2 O 2 to the glial cells, GSH strongly prevented cell death, but both pretreatment and combined treatment of leptin at respective doses were not capable to block the H 2 O 2 -induced glia death. Respective leptin treatment for 24 h did not also change the glial cell MDA level. There are, however, studies showing the antioxidant capacity of leptin (Ozata et al. 2000) . Erkasap et al. (2006) showed that leptin protects the cardiac myocyte cultures from hypoxic damage. In another study on mouse strains, it was concluded that leptin is involved in the protective mechanism against the tumour necrosis factor α toxicity (Takashi et al. 1999) . Conversely, Xu et al. (2004) found that leptin elevates endothelin-1 and reactive oxygen species levels, resulting in hypertrophy of cultured neonatal rat cardiac myocytes. They suggested that the endothelin-1-endothelin(A) receptorreactive oxygen species pathway may be involved in cardiomyocyte hypertrophy induced by leptin (Xu et al. 2004) . Similarly, leptin at the doses of 1, 10 and 100 ng/mL induces oxidative stress in human umbilical vein endothelial cells as assessed by the oxidation of 2 I ,7 Idichlorodihydrofluorescein (Bouloumie et al. 1999) . In a study on C6 glioma cells, leptin induced iNOS both at mRNA and protein level and potentiated cytokineinduced iNOS; these doses are, however, 3-and 10-fold higher than our highest dose (Mattace-Rasso et al. 2006) .
In conclusion, 100 and 1000 ng/mL of leptin treatment for 72 h increases primary mixed glial cell survival and leptin doses up to 1000 ng/mL do not show antioxidant or oxidant activity. Further studies should be conducted to clarify detailed action of leptin on glia.
